Edgar Ribi Papers, 1950-1986  PDF  XML

Overview of the Collection

Creator
Ribi, Edgar, 1920-1986
Title
Edgar Ribi Papers
Dates
1950-1986 (inclusive)
Quantity
84.75 linear feet
Collection Number
Mss 197
Summary
This collection contains records generated and collected by Edgar Ribi over the course of his professional career as an academic, public employee, and for-profit researcher. The bulk of collection materials date from his years researching the fine structure of microbial cells, immunologically-active cell constituents, and vaccines for the National Institutes of Health (particularly at the National Institute of Allergy and Infectious Diseases Laboratory in Hamilton, Montana).
Repository
University of Montana, Mansfield Library, Archives and Special Collections
Archives and Special Collections
Maureen and Mike Mansfield Library
University of Montana
32 Campus Dr. #9936
59812-9936
Missoula, MT
Telephone: 406-243-2053
Fax: 406-243-4067
library.archives@umontana.edu
Access Restrictions

Researchers must use collection in accordance with the policies of Archives and Special Collections, the Maureen and Mike Mansfield Library, and the University of Montana-Missoula.

Languages
English, German, Russian
Sponsor
Funding for encoding this finding aid was provided through a grant awarded by the National Endowment for the Humanities. Funding for preparing this finding aid was provided through a grant awarded by the National Historic Publications and Records Commission.


Biographical NoteReturn to Top

Edgar Ribi was born September 5, 1920, in Zurich, Switzerland. Ribi attended the Bern Institute of Technology from 1937 to 1940. He graduated with a diploma in Chemical Engineering. Ribi then attended the University of Bern and received Ph.D's in chemistry, physics, and mineralogy between 1940 and graduated magna cum laude in 1948. His thesis was on chemistry, morphology, and the crystal structure of inorganic colloids, examined by electron microscopy and electron and x-ray diffraction.

He married Karin Smith in 1951 and sired two children: Nils Andrew, and Hans Oliver. The Ribis came to the U.S. and became naturalized citizens.

From 1946 to 1948 Ribi was the instructor of analytical chemistry at Bern, Switzerland. He became the research associate to Professor T. Svedberg at the Institute of Physical Chemsitry in Upsala, Sweden. While there, Ribi also worked to perfect techniques on electron microscopy at the National Institutes of Health (NIH) Labs in Bethesda, Maryland. In 1951, he became the research associate to Professor A Tiselius, and worked on plant and animal fibrous tissues. From 1952 to 1958, he was a visiting scientist at National Institute of Allergy and Infectious Diseases (NIAID) for NIH. He reseached the fine structure of microbial cells and the immunologically-active cell constituents and vaccines. He also invented the Ribi Cell Fractionator, which broke cells open without harming them. From 1959 until his retirement in 1980 he was the head of the biophysics section of the NIAID Lab in Hamilton, Montana.

In 1981, he founded Ribi ImmunoChem Research, which became a leading biochemical research company, in Hamilton, Montana. The company worked on anti-cancer agents, anti-infectious agents, and super vaccines. Some of the products it developed were Ribigen (an anti-tumor agent used in cattle), Detox (a human anti-cancer agent), and Ovamid (an anti-tumor agent intended for treating ovarian and cervical cancers). The company received numerous patents for its products. Ribi ImmunoChem was acquired in 1999 by Corixa Corporation for $58.5 million, and continued operations in Hamilton.

Content DescriptionReturn to Top

This collection contains records generated and collected by Edgar Ribi over the course of his professional career as an academic, public employee, and for-profit researcher. The bulk of collection materials date from his years researching the fine structure of microbial cells, immunologically-active cell constituents, and vaccines for the National Institutes of Health (particularly at the National Institute of Allergy and Infectious Diseases Laboratory in Hamilton, Montana). Collection materials include biographical materials on Edgar Ribi, correspondence directly related to research conducted at the Hamilton lab, research data files and reports, Ribi's written contributions to the field, records from the Ribi ImmunoChem company, and graphic representations of lab research.

These materials document a partial history of federal research at the laboratory in Hamilton and lend insights into the breadth of/developments within infectious disease and oncological research spanning the years during which these fields transformed from obscure specialities into major international health care commitments.

Use of the CollectionReturn to Top

Restrictions on Use

Researchers are responsible for using in accordance with 17 U.S.C. and any other applicable statutes. Copyright not transferred to the University of Montana.

Preferred Citation

[Name of document], Edgar Ribi Papers, Archives and Special Collections, The University of Montana-Missoula.

Administrative InformationReturn to Top

Arrangement

The collection is arranged in seven series:

Series I: Biographical, 1951-1980, 0.25 linear feet

Series II: General Correspondence, 1950-1986, 10.5 linear feet

Series III: Research, 1953-1980, 51 linear feet

Series IV: Speeches and Writings, 1954-1986, 13.0 linear feet

Series V: Ribi ImmunoChem, 1981-1986, 4.0 linear feet

Subseries 1: Company, 1981-1986, 3.0 linear feet

Subseries 2: Financial, 1981-1984, 1.0 linear feet

Series VI: Electron Micrographs, undated, 5.5 linear feet

Series VII: Chromatographs, undated, 0.5 linear feet

Series VIII: Photographs, 1928-1975, 9 images

Custodial History

The papers were in the possession of the Ribi family until donation to the Archives.

Acquisition Information

Gift of Nils and Hans Ribi, 1993.

Processing Note

The actions of the original processors are unknown. In 2004, the collection was divided into series and fully described. Materials related to Ribi ImmunoChem, which had been restricted by the donors until 2003, were added at this time; some publications not produced by or directly related to the company were discarded.


Detailed Description of the CollectionReturn to Top

Series I:  Biographical, 1951-1980Return to Top

0.25 linear feet

This series contains formal biographical statements regarding Edgar Ribi, employment records from his years of service with the National Institutes of Health, and some internal correspondence regarding management decisions at the National Institute of Allergy and Infectious Diseases Laboratory in Hamilton, Montana.

Container(s) Description Dates
Box/Folder
1/1
Employment data
1951
1/2
Employment data
1951
1/3
Employment data
1952
1/4
Employment data
1953
1/5
Employment data
1954-1958
1/6
Employment data
1960-1964
1/7
Employment data and bibliography
1968-1980

Series II:  General Correspondence, 1950-1986 Return to Top

10.5 linear feet

This series contains extensive sequences of incoming and outgoing correspondence generated by, received by, or forwarded to Edgar Ribi during his years of service at the National Institute of Allergy and Infectious Diseases Laboratory in Hamilton, Montana. In most instances correspondence sequences extend across several folders and contain submissions from a diverse collection of individuals representing National Institutes of Health administrators, staff from Federal regulatory agencies, academic and private researchers, and fellow Laboratory staff members.

Container(s) Description Dates
Box/Folder
2/1
American Lung Association
1969-1978
2/2
American Lung Association
1979-1986
2/3
Asselinau-Lederer-Jolles-Tanaka
1967-1969
2/4
Asselinau-Lederer-Jolles-Tanaka
1967
2/5
Azuma, Ichino
1978-1981
2/6
Azuma, Ichino
1976-1978
2/7
Azuma, Ichino
1972-1976
2/8
Azuma, Ichino
1970-1972
2/9
Azuma, P3 structure
undated
2/10
Azuma, P3 structure
undated
2/11
Azuma, Ichino
undated
2/12
Azuma, Ichino
undated
2/13
Azuma, Ichino
undated
3/1
"A" Miscellaneous
1951-1961
3/2
"A" Miscellaneous
1962-1967
3/3
"A" Miscellaneous
1967-1979
3/4
"A" Miscellaneous
1984
3/5
Ballou
1964-1975
3/6
Ballou
1965-1975
3/7
Barclay, William
1964-1966
3/8
Barclay, William
1967-1975
3/9
Barclay, William
undated
3/10
Brehmer, Werner
1966-1968
3/11
Brehmer, Werner
1968-1970
3/12
Brehmer, Werner
1970
3/13
Brehmer, Werner
1971-1972
3/14
Brehmer, Werner
1972-1973
3/15
Brehmer, Werner
1973
4/1
Brehmer, Werner
1974-1975
4/2
Brehmer, Werner
1975-1976
4/3
Brehmer, Werner
1976
4/4
Brehmer, Werner
1976
4/5
Brehmer, Werner
1977
4/6
Brehmer, Werner
1977-1978
4/7
Brehmer, Werner
1978-1979
4/8
Brehmer, Werner
1979
4/9
"B" Miscellaneous
1950-1961
4/10
"B" Miscellaneous
1960-1968
4/11
"B" Miscellaneous
1964-1972
4/12
"B" Miscellaneous
1974-1979
4/13
"B" Miscellaneous
1981-1986
5/1
Cantrell, John-Williams, Jim
1979
5/2
"C" Miscellaneous
1954-1961
5/3
"C" Miscellaneous
1962-1968
5/4
"C" Miscellaneous
1968-1973
5/5
"C" Miscellaneous
1973-1979
5/6
"C" Miscellaneous
1981-1982
5/7
"C" Miscellaneous
1984-1985
5/8
D'Aoust, Joan
1984
5/9
Davis, Dorland
1964-1976
5/10
Davis Primate Experiment
1966
5/11
Davis Primate Experiment
1965-1966
5/12
Davis Primate Experiment
1967-1972
5/13
Davis Primate Experiment
1972
5/14
Difco
1956-1972
5/15
DiLuzio, N. R.
1976
6/1
"D" Miscellaneous
1953-1961
6/2
"D" Miscellaneous
1962-1968
6/3
"D" Miscellaneous
1968-1979
6/4
"D" Miscellaneous
1984-1986
6/5
"E" Miscellaneous
1951-1961
6/6
"E" Miscellaneous
1962-1967
6/7
"E" Miscellaneous
1969-1979
6/8
"E" Miscellaneous
1985
6/9
Fales, Henry M.
1972
6/10
Fine, Jacob
1964-1967
6/11
Fukushi, Kazue
1960-1968
6/12
Fukushi, Kazue
1966-1978
6/13
"F" Miscellaneous
1951-1961
6/14
"F" Miscellaneous
1962-1966
6/15
"F" Miscellaneous
1966-1972
6/16
"F" Miscellaneous
1974-1978
6/17
"F" Miscellaneous
1980-1985
7/1
Goode, Dan
undated
7/2
Goren, Mayer
1971-1973
7/3
Goren, Mayer
1973-1975
7/4
Goren, Mayer
1973-1976
7/5
Granatek-Gutterman-Hersh
1974-1976
7/6
Granatek-Gutterman-Hersh
1976
7/7
Granatek-Gutterman-Hersh
1976
7/8
Granatek-Gutterman-Hersh
1975-1977
7/9
Granatek-Gutterman-Hersh
1977
7/10
Granatek-Gutterman-Hersh
1976-1979
7/11
Granatek-Gutterman-Hersh
1979
7/12
Granatek, Christine
1980-1983
7/13
Gray, Gary
1972-1975
7/14
Gray, Gary
1975
7/15
Gray, Gary
1975-1976
8/1
Gray, Gary
1976-1977
8/2
Gutterman-Hersh
1977-1979
8/3
Gutterman-Hersh
1980
8/4
"G" Miscellaneous
1951-1960
8/5
"G" Miscellaneous
1961-1965
8/6
"G" Miscellaneous
1962-1973
8/7
"G" Miscellaneous
1973
8/8
"G" Miscellaneous
1973-1977
8/9
"G" Miscellaneous
1977-1979
8/10
"G" Miscellaneous
1980-1986
8/11
Harris, S. C.
1980
8/12
"H" Miscellaneous
1967-1979
8/13
H" Miscellaneous
1984-1986
8/14
"H" Miscellaneous
1950-1961
8/15
"H" Miscellaneous
1963-1967
9/1
Imaeda, Dr. Tamotsu
1966-1967
9/2
Imaeda, Dr. Tamotsu
1967-1972
9/3
Infection and Immunity
1976-1977
9/4
Infection and Immunity
1976-1979
9/5
Infection and Immunity
1978-1979
9/6
Isenberg, Dr. Henry
1961-1974
10/1
Ivan Sorvall Incorporated Cell Fractionator
1958-1960
10/2
Ivan Sorvall Incorporated Cell Fractionator
1950-1961
10/3
Ivan Sorvall Incorporated Cell Fractionator
1961
10/4
Ivan Sorvall Incorporated Cell Fractionator
1962
10/5
Ivan Sorvall Incorporated Cell Fractionator
1962-1963
10/6
Ivan Sorvall Incorporated Cell Fractionator
1963
10/7
Ivan Sorvall Incorporated Cell Fractionator
1964-1965
10/8
Ivan Sorvall Incorporated Cell Fractionator
1965-1966
10/9
Ivan Sorvall Incorporated Cell Fractionator
1966
10/10
Ivan Sorvall Incorporated Cell Fractionator
1967
10/11
Ivan Sorvall Incorporated Cell Fractionator
1967-1972
10/12
Ivan Sorvall Incorporated Cell Fractionator
1972-1973
11/1
"I" Miscellaneous
1958-1974
11/2
"I" Miscellaneous
1984
11/3
Jenkin, Howard M. Ph.D.
1971
11/4
"J" Miscellaneous
1957-1971
11/5
"J" Miscellaneous
1973-1979
11/6
"J" Miscellaneous
1983-1985
11/7
Kato, Dr. Masahiko
1972-1976
11/8
Kelly, Michael
undated
11/9
Koffler, Dr. Henry
1957-1960
11/10
Koffler, Dr. Henry
1959-1960
12/1
Koffler, Dr. Henry
1959-1960
12/2
"K" Miscellaneous
1950-1963
12/3
"K" Miscellaneous
1964-1968
12/4
"K" Miscellaneous
1969-1970
12/5
"K" Miscellaneous
1970-1979
12/6
"K" Miscellaneous
1977
12/7
"K" Miscellaneous
1980-1986
12/8
Lackman, David
1975-1984
12/9
Landy, Dr. Maurice
1966-1973
12/10
Larson, Dr. Carl L.
1961-1963
12/11
Larson, Dr. Carl L.
1963-1964
12/12
Larson, Dr. Carl L.
undated
12/13
Lederer, Dr. Edgar
undated
12/14
Lederer, Dr. Edgar
1980
13/1
Luderitz, Milner, Niwa
1968-1971
13/2
"L" Miscellaneous
1951-1961
13/3
"L" Miscellaneous
1962-1974
13/4
"L" Miscellaneous
1971-1973
13/5
"L" Miscellaneous
1982-1985
13/6
Manuscript Reviews
1984-1985
13/7
Malmgren, Heden
1963-1966
13/8
Matsumoto, Dr. Junjiro
1969-1971
13/9
McGrady, Pat
undated
13/10
McLauglin, Dr. Charles DVM, Ph.D.
1974
13/11
McLauglin, Dr. Charles DVM, Ph.D.
1976-1977
13/12
McLauglin, Dr. Charles DVM, Ph.D.
1978
13/13
Medora, Rustem
1972
13/14
Meyer, K.F. M.D.
1970-1972
13/15
Microbial Toxins, 8th World Congress
Aug. 1985
13/16
Middlebrook, Gardner M.D.
1967-1968
13/17
Milner, Kelsey
1963-1968
13/18
Milner, Kelsey
1968-1973
14/1
Mitchell, M. S.
1980
14/2
Mizuno, Yuske
1976-1978
14/3
Morton, Harry
1956
14/4
Munoz, John J.
1958
14/5
Muraoka, Susy
undated
14/6
"M" Miscellaneous
1951-1961
14/7
"M" Miscellaneous
1963-1966
14/8
"M" Miscellaneous
1966-1972
14/9
"M" Miscellaneous
1971-1978
14/10
"M" Miscellaneous
1973-1977
14/11
"M" Miscellaneous
1978-1979
14/12
"M" Miscellaneous
1980-1984
14/13
"M" Miscellaneous
1984-1986
14/14
Nauts, Helen C.
1977-1978
14/15
Neter, Erwin
1965-1970
14/16
Nikaido, Hiroshi
undated
15/1
Niwa, Makoto
undated
15/2
Niwa, Makoto
1965-1968
15/3
Niwa, Makoto
1968-1978
15/4
Noll and Braude
1961-1963
15/5
Noll and Braude
undated
15/6
Norling, Annalisa
1957-1965
15/7
Nowotny, A.H.
undated
15/8
Nowotny, A.H.
1959-1960
15/9
Nowotny, A.H.
1960-1962
15/10
Nowotny, A.H.
1965
15/11
Nowotny, A.H.
1975-1979
15/12
"N" Miscellaneous
1951-1979
15/13
"N" Miscellaneous
1983-1986
15/14
Oucherlony, O.
1970-1972
15/15
"O" Miscellaneous
1955-1977
15/16
"O" Miscellaneous
1980-1984
16/1
Dagand
1982-1983
16/2
Patents
1984
16/3
Pertline, T.D.
1957-1962
16/4
"P" Miscellaneous
1951-1976
16/5
"P" Miscellaneous
1971-1979
16/6
"P" Miscellaneous
1976-1983
16/7
Ribi, E.
1949
16/8
Ribi, E.
April-September 1981
16/9
Ribi, E.
October-December 1981
16/10
Ribi, E.
January-June 1982
16/11
Ribi, E.
July-November 1982
16/12
Ribi, E.
November-December 1982
16/13
Ribi, E.
1983
16/14
Ribi, E.
1984
16/15
Ribi, E.
1985
16/16
Ribi, E.
1986
17/1
Richman
1978-1979
17/2
Rudbach, Jon A.
1963-1971
17/3
"R" Miscellaneous
1950-1966
17/4
"R" Miscellaneous
1965-1966
17/5
"R" Miscellaneous
1967-1977
17/6
"R" Miscellaneous
1977-1978
17/7
"R" Miscellaneous
1983-1985
17/8
Salvin, Samuel B.
1964-1986
17/9
Schmidt, Davis
1966
17/10
Seal, Dr. John
1966-1967
17/11
Seal, Dr. John
1966-1977
17/12
Shands, Joeseph W.
1962-1964
17/13
Shilo, Moshe
1963-1965
17/14
Small business Innovation Research
1983-1984
17/15
Small Business Innovation Research
1984
17/16
Smith, David, T.
1959-1971
18/1
Smith, Donald
1959-1966
18/2
Smith, Donald
1966-1967
18/3
Smith, Donald
1966-1973
18/4
Smith, Donald
1968
18/5
Smith, Ian
1963-1964
18/6
Sobel-Janicki
1969-1972
18/7
Sorkin, Ernst
1961
18/8
Sorkin, Ernst
1962-1963
18/9
Spink, Dr. Wesley
1964
18/10
Stewart, Gwen
1962
18/11
Strain, Mike
1961-1976
18/12
Suzuki, F.
1981
18/13
"S" Miscellaneous
1952-1961
18/14
"S" Miscellaneous
1959-1965
19/1
"S" Miscellaneous
1965-1972
19/2
"S" Miscellaneous
1972-1977
19/3
"S" Miscellaneous
1978-1979
19/4
"S" Miscellaneous
1980-1986
19/5
Takayama, Kuni
1975-1976
19/6
Takayama, Kuni
1977
19/7
Tarmina, David
1964-1976
19/8
Tauber, Henry
1960-1962
19/9
Toubiana, Raoul
1975-1978
19/10
Toubiana, Raoul
1975-1978
19/11
Toubiana, Raoul
1975-1978
19/12
Toubiana, Raoul
1975-1978
19/13
Toubiana, Raoul
1975-1978
19/14
Toubiana, Raoul Review
undated
19/15
Toubiana, Raoul Review
undated
20/1
"T" Miscellaneous
1958-1979
20/2
"T" Miscellaneous
1980-1985
20/3
United States Department of Agriculture
1983
20/4
"U" Miscellaneous
1956-1983
20/5
Von Eschen
undated
20/6
Von Eschen
undated
20/7
Von Eschen
undated
20/8
Von Eschen
undated
20/9
Von Eschen
undated
20/10
Von Eschen
undated
20/11
Von Eschen
undated
20/12
Von Eschen
undated
20/13
Vosicka, Gerald
1977-1979
20/14
Vosicka, Gerald
1977-1979
20/15
Vosicka, Gerald
1977-1979
21/1
Vosicka, Gerald
1978-1979
21/2
Vosicka, Gerald
1979
21/3
Vosicka, Gerald
1979
21/4
"V" Miscellaneous
1962-1975
21/5
"V" Miscellaneous
1975-1985
21/6
Walker, Robert
1975
21/7
Ward, Jack
1985-1986
21/8
Watson, Dennis W.
1960-1964
21/9
Weibull, Claes
1959-1964
21/10
Weibull, Claes
1961-1965
21/11
Weibull, Claes
1966-1973
21/12
Weibull, Claes
1982-1983
21/13
Wepsic, Terry
1975-1977
21/14
Westphal, Otto
1959-1967
21/15
Wheat, Robert
1963-1971
21/16
Wheat, Robert
1968
21/17
Williams, Curtis A.
1964-1966
22/1
Williams, Jim
1978
22/2
Winters, Wendall
1978-1979
22/3
Winters, Wendall
undated
22/4
Wright, G.L.
1972-1974
22/5
"W" Miscellaneous
1953-1965
22/6
"W" Miscellaneous
1965-1975
22/7
"W" Miscellaneous
1975
22/8
"W" Miscellaneous
1975-1979
22/9
"W" Miscellaneous
1981-1985
22/10
Yamamoto, Ken-Ichi
1967-1976
22/11
Yamamoto, Ken-Ichi
1974-1985
22/12
Yarkoni, Eliyahu
1980
22/13
"Y" Miscellaneous
1959-1975
22/14
"Y" Miscellaneous
1983-1984
22/15
"Z" Misc
1982
22/16
Miscellaneous
undated

Series III:  Research Files, 1953-1980Return to Top

51 linear feet

This series contains extensive research records generated or collected by Edgar Ribi. Series materials were generated throughout Ribi's academic and professional career; however, the largest portion date from the period of Ribi's employment at the National Institute of Allergy and Infectious Diseases Laboratory in Hamilton, Montana. These files provide detailed documentation of hypotheses, procedures, results (including multi-variable data charts), and adjustments from Ribi's work and those of his colleagues in the field of immunology and infectious disease research.

Container(s) Description Dates
Box/Folder
23/1
Skin Tests No. 1
23/2
Skin Tests No. 2
23/3
Bob List No. 2
23/4
Bob List No. 3
23/5
Bob List No. 5
23/6
Bob List No. 4
24/7
Bob List No. 6
24/8
Toxicity Tests No. 1
24/9
Toxicity Tests No. 2
24/10
Toxicity Tests No. 3
24/11
Salmonella Se 31-62 No. 3
24/12
Salmonella Se 63-Se 101 No. 4
25/13
Salmonella Se 102-Se 126 No. 5
25/14
Salmonella Se 127-Se 147 No. 6
25/15
Salmonella Se 148-Q 1 # Q No. 7
25/16
Histo Salmonella Se 1-Se 30 No. 2
25/17
Electron Micrographs Electron Microscope Int. Copies
25/18
Electron Micrographs II Electron Microscope 186-368 No. 2
26/19
Electron Micrographs III Electron Microscope 369-539 No. 3
26/20
Electron Micrographs IV Electron Microscope 540-720 No. 4
26/21
Electron Micrographs V 721
26/22
Electron Microscope No. 1
26/23
Siemens No. 1
26/24
Thuli Histo Crypto Ribi No. 1
26/25
Electrophoresis
27/26
X-Ray Diffraction
27/27
Bethesda-Uppsala
27/28
Endotoxins, Haskins 1
27/29
Endotoxins, Haskins 2
27/30
Endotoxins, Hasknis 3
27/31
Endotoxin Fractionation, Dan Goode
28/32
Myc. Protoplasm Fractionations
28/33
Cell Walls, Simmons
28/34
Cell Walls, Simmons
28/35
Protection to Tuberculosis Male Guinea Pig 's
28/36
ERIC I
28/37
ERIC II
29/38
Cultures No. 1
29/39
Seed Cultures List No. 2
29/40
Bioassays
29/41
B. Pertussis
29/42
B. Tularense
29/43
FDA BCG-Cell Wall Skeletons
29/44
BCG Parvum
30/45
E. Coli II
30/46
R. Anderson
30/47
Nitrogen Det., Dan Goode
30/48
Rickettsiae, Neaves No.1
30/49
Q-Fever
30/50
S. Minnesota R595
31/51
S. Marcescens
31/52
Sty 17 and others
31/53
Strep
31/54
Tuberculosis, Ribi, List 1, No. 1
31/55
Sample Distribution
1976
31/56
Notes
1973, 1978, 1979
32/57
Personal Letter- Spritznagel, DuBois
32/58
Various Extractions Experiments Jim Simmons
32/59
Alkaline Degradation of Endotoxin, M. Niwa
33/60
Endotoxins Chemical Analyses I
33/61
Endotoxins Chemical Analyses II
33/62
Endotoxin-Bioassays I; Correspondences - Dr. Landy
34/63
Endotoxin-Bioassays II; Correspondence-Dr. Landy
34/64
Endotoxin-Bioassay III; Correspondence-Landy, Suter, Smith
34/65
Endotoxins IV
35/66
Endotoxins V
35/67
Endotoxins VI
35/68
Endotoxins VII
36/69
Ultracentrifugation Record I
36/70
Endotoxins, Ultracentrifugation I
36/71
Endotoxins, Ultricentrifugation II
37/72
Ultricentrifugation III
37/73
Endotoxins Physical Measurements I
37/74
Endotoxins Planned Work
38/75
Experiment of Endotoxin from S. Typhinimurium, K. Amano
38/76
Tuberculosis
38/77
T.B, Mouse Protection Tests
1965
39/78
Tuberculosis Summary Data
1965-1966
39/79
Tuberculosis Miscellaneous Proposal for Experiment
40/80
Tuberculosis Protection Tests
1966
40/81
Tuberculosis Summary Data
1967
40/82
Tuberculosis Protection Tests
1967
41/83
Tuberculosis Protection Tests
1968
41/84
Tuberculosis Protection Tests
1968-1969
41/85
Tuberculosis Protection Tests
1969
42/86
Tuberculosis Protection Tests
1970
42/87
Tuberculosis Protection Tests
1970
42/88
Tuberculosis Protection Tests
1971
43/89
Tuberculosis Protection Tests
1972
43/90
Granuloma Experiment
1972-1973
43/91
Tuberculosis Protection Tests
1972-1973
44/92
Tuberculosis Protection Tests
1973
44/93
Tuberculosis Protection Tests
1974
44/94
Tuberculosis Protection Tests
1974
45/95
Tuberculosis Protection Tests
1975
45/96
Experiments
1978
45/97
Protection and Granuloma
1975
46/98
Tuberculosis Centrichrome
1971
46/99
Tuberculosis Centrichrome
1970
46/100
Tuberculosis Centrichrome
47/101
Pyrogen Tests, P.3-3-77, P.4-25-77
47/102
Pyrogen Tests
4-29-1977, 6-6-1977
47/103
Current
48/104
Pyrogen Tests, 1
6-13-1977, 8-1-1977
48/105
Pyrogen Tests, 3
10-28-1977, 11-28-1977
48/106
Pyrogen Tests, 6
3-17-1978, 4-28-1978
49/107
Pyrogen Tests, 7
5-3-1978, 7-7-1978
49/108
Pyrogen Tests, 8
7-10-1978, 8-18-1978
49/109
Pyrogen Tests, 9
8-21-1978, 10-23-1978
50/110
Toxicity and Pyrogen Tests, ET
1978-1979
50/111
Pyrogen Tests, 10
10-27-1978, 12-22-1978
50/112
Pyrogen Tests, 11
1-5-1979, 2-26-1979
51/113
Pyrogen Tests, 12
3-2-1979, 4-20-1979
51/114
Pyrogen Tests, 13
4-23-1979, 6-8-1979
51/115
Pyrogen Tests, 14
6-11-1979, 7-27-1979
52/116
Pyrogen Tests, 15
8-3-1979, 9-21-1979
52/117
Pyrogen Tests, 16
9-28-1979, 11-16-1979
52/118
Pyrogen Tests, 17
11-19-1979, 12-28-1979
53/119
Pyrogen Tests, 18
1-15-1980, 2-26-1980
53/120
Sugars I
53/121
Endotoxin Detergent I
54/122
Methyl Pentose, Citric Acid
54/123
Nucleic Acid Analysis
54/124
Hexose
55/125
Hexosamine
1961-1969
55/126
Heptose Detn
55/127
Hexose
1961-1969
56/128
Total Carbohydrate
1962-1969
56/129
Smack-Heroin
56/130
Smack-Heroin, Literature
57/131
Smack-Heroin, Literature
57/132
KDO-DDS Old Method
57/133
Niotrogen
1961-1965
58/134
Phosphorus
1961-1965
58/135
KDO-DDS
58/136
Hexosamine
59/137
Fatty Acids
59/138
Fatty Acids
1961-1969
59/139
Tumor Work Notes I
60/140
Tumor Work Notes II
60/141
Guinea Pig Gran. Tumor Suppression, MIF, Regression
1974-1979
60/142
Tumor Cell Experiment
61/143
Raffel-Mackaness
61/144
Toxicity Tests
1974 Orley, Results and Protocals
61/145
Landy
62/146
M. Strain
62/147
M. Strain
62/148
M. Strain
63/149
M. Strain
January 1976, January 1978
63/150
Parke, Davis and Company
63/151
Dr. Philip Gerhardt
64/152
Malmgren
64/153
Dr. Erwin Neter
64/154
Soren Orley
65/155
Ichiro
65/156
Dayli Notes
65/157
AAA, Beckman
66/158
Centrichrome BCG No. 1
66/159
Centrichrome
66/160
Centrichrome, Pesticides
66a/161
Whole Cell Extracts, P.3, CHcl3 Experiment's
66a/162
Autorediography
66a/163
Electron Microscope Photos, Tumor. K. Fukushi
66b/164
Line 10 and Regl-Pec Photos
66b/165
Ragweed Pollen Antigens Ultracentrifuge III Mycobacterial Culture Book 2, 12-21-77-, Code No.336
66c/167
Mycobacterial Culture Record
4-27-1973, 12-15-1977
66c/168
Culture Records
66c/169
B4 Studies
66d/170
Summary Chemical Analysis
66d/171
Lipids Studies
66d/172
Total Carbohydrate
66e/173
Pseudogen
66e/174
Immunization Records, Antisera
66e/175
Nonspecific Experiments No. 305-396
66f/176
Toxicity Tests
6-22-1979, 11-22-1978
66f/177
Bioassays, Others
66f/178
Collaborations Experiment Summary
67/179
CELD 50, No. 1
6-14-1977, 7-26-1978
67/180
CELD 50, No. 2
8-1-1978, 5-29-1979
67/181
CELD 50, No. 3
6-5-1979, 7-22-1980
68/182
CELD 50, No. 4
8-4-1950
68/183
P. Pestis
68/184
Others
10-28-1977
69/185
Miscellaneous Charts
69/186
Miscellaneous Charts
69/187
Miscellaneous Charts
70/188
S. Marescus
70/189
Pyrogen Summary
70/190
Endotoxins, Others, Correspondences
71/191
Miscellaneous Papers
71/192
Experimentsl Results
71/193
Autoclave Charts
71/194
United States Department of Agriculture License Applications
72/195
Protocol Book
72/196
G.B. Mackaulss, Cellular Immunity
72/197
Notes, Addresses
72/198
Miscellaneous Notes
72/199
Notes, Study, Preparation for Boulder Colorado
1958
72/200
D2o Exchange from Bern
72/201
More Notes from Bern
73/1
Notes for Future Centrichhrome Publications
73/2
Notes - Centrifigul Chromotography
73/3
Notes, Miscellaneous, Centrichrome Review; Marijuana
73/4
M.S., Affinity Chromtography
73/5
Chromotography
73/6
High Speed Liquid Chromotography
73/7
H.S.L. Chromo
73/8
H.S.L. Chromo
73/9
Centri - Chromo
73/10
Centri - Chromo
74/1
Chromo Reprints
74/2
Chromo Reserve Copies, Pictures
74/3
TLC Centri-Chromo Germicides, Rhoades
74/4
Endotoxins Centri-Chrome
1970
74/5
Centri-Chrome Procedures
74/6
Marijuana: Cannabinoids by Centri-Chromo
74/7
Chromo's from Syp. on Bacteria Endotoxins SAB
1961
74/8
Centri-Chromo Diagram
74/9
Centri-Chromo Protocols, Results, IS Manual
74/10
Chromo - Lipids
74/11
Centri-Chromo
74/12
Chromo Results
74/13
Chromo Results
75/1
Centri-Chromo Subfractions V.I Book 2
75/2
Centri-Chromo Subfractions V.I Book 2
75/3
Centri-Chromo Subfractions V.I Book 3
75/4
Centri-Chromo Subfractions V.I Book 3
75/5
Centri-Chromo Subfractions V.II Book 4
75/6
Centri-Chromo Subfractions V.II Book 4
75/7
Centri-Chromo Subfractions V.II Book 5
75/8
Centri-Chromo Subfractions V. II Book 5
76/1
Centri-Chromo Subfractions V.III Book 6
76/2
Centri-Chromo Subfractions V. III Book 6
76/3
Centri-Chromo Subfractions V. III Book 7
76/4
Centri-Chromo Subfractions V. III Book 7
76/5
Centri-Chromo Subfractions V. IV Book 8
76/6
Centri-Chromo Subfractions V. IV Book 8
76/7
Centri-Chromo Subfractions V. IV Book 9
76/8
Centri-Chromo Subfractions V. IV Book 9
76/9
Centri-Chromo Subfractions V. V Book 10
77/1
Centri-Chromo Subfractions V. V Book 10
77/2
Centri-Chromo Subfractions V. V Book 11
77/3
Centri-Chromo Subfractions V. V Book 11
77/4
Centri-Chromo Photos
77/5
Centri-Chromo Photos/Results
77/6
Centri-Chromo Photos No. 30
77/7
Centri-Chromo Photos/Graphs No. 29
77/8
Centri-Chromo Photos No. 28
77/9
Centri-Chromo Paper No. 26
77/10
Centri-Chromo Photos/Figures No. 25
77/11
Centri-Chromo Figures 23,24,22,21,20,19,8,2,1,37,36,34,33,31,32,9,12
77/12
Centri-Chromo Figures 11,10,6,7,13,35,2,27,14,15,18,17
77/13
Centri-Chromo Steroids
77/14
Centri-Chromo Marijuana
77/15
Centri-Chromo Dr. Milner
78/1
Guinea Pig Skin Tests
7-29-1977
78/2
Guinea Pig - P3 Toxicity EO20775-T
78/3
Guinea Pig Toxin Tests
78/4
Guinea Pig Experiments 11-2-67 and 11-4-68 Undependable Results
78/5
Guinea Pig 4-3-68
78/6
Guinea Pig Tumor 092680R
78/7
Guinea Pig 103180R
78/8
Guinea Pig Tumor 101080R
78/9
Guinea Pig Tumor 100380R
78/10
Guinea Pig Tumor 091280R
78/11
Guinea Pig Tumor 090580R
78/12
Guinea Pig Tumor 032180R
78/13
Guinea Pig Tumor 082280R
78/14
Guinea Pig Tumor 082980R
78/15
Guinea Pig Tumor 081580R
78/16
Guinea Pig Tumor 081480R
78/17
Guinea Pig Tumor 080180R
78/18
Guinea Pig Tumor 071880R
78/19
Guinea Pig Tumor 060680R
78/20
Guinea Pig Tumor 062780R
78/21
Guinea Pig Tumor 070380R
78/22
Guinea Pig Tumor 061380R
78/23
Guinea Pig Tumor 102480R
78/24
Guinea Pig Tumor 110780R
78/25
Guinea Pig Tumor 041379R
78/26
Guinea Pig Tumor 010480R
78/27
Guinea Pig Tumor 053080R
78/28
Guinea Pig Tumor 052380R
78/29
Guinea Pig Tumor 050980R
78/30
Guinea Pig Tumor 050280R
78/31
Guinea Pig Tumor 042580R
78/32
Guinea Pig Tumor 041880R
78/33
Guinea Pig Tumor 041180R
78/34
Guinea Pig Tumor 032880R
78/35
Guinea Pig Tumor 031480R
78/36
Guinea Pig Tumor 022980R
78/37
Guinea Pig Tumor 021580R
78/38
Guinea Pig Tumor 020880R
78/39
Guinea Pig Tumor 012580R
79/1
Bethesda Tumor Experiment 1st Production of Tumor Immunology
79/2
Bethesda Tumor Experiment 1st Regsn of Pre-est. Tumor
79/3
Guinea Pig Tumor Regression Experiments
79/4
Tumor Experiment
79/5
Vaccine Preparation
79/6
Tumor Regression Experiment
79/7
Mouse Tumor Protocol
79/8
Tumor System Protocol
79/9
Summary Tables
79/10
Guinea Pig Tumor 122879R
79/11
Guinea Pig Tumor 113079 Swartzman
79/12
Guinea Pig Tumor 112379R
79/13
Guinea Pig Tumor 101979R
79/14
Guinea Pig Tumor 092779R
79/15
Guinea Pig Tumor 083179R
79/16
Guinea Pig Tumor 080379R
79/17
Guinea Pig Tumor 072079R
79/18
Guinea Pig Tumor 070679R
79/19
Guinea Pig Tumor Experiment 073179R
79/20
Guinea Pig Tumor 060879R
79/21
Guinea Pig Tumor 060179R
79/22
Guinea Pig Tumor 051879R
79/23
Guinea Pig Tumor 042779R
79/24
Guinea Pig Tumor 033079R
79/25
Guinea Pig Tumor 031679 Cantrell
79/26
Guinea Pig Tumor 030279R
80/1
Guinea Pig Tumor 022379R
80/2
Guinea Pig Tumor 020279R
80/3
Guinea Pig Tumor 012679R
80/4
Guinea Pig Tumor 010579R
80/5
Guinea Pig Tumor 120878R
80/6
Guinea Pig Tumor 110978R
80/7
Guinea Pig Tumor 102078R
80/8
Guinea Pig Tumor 092278R
80/9
Guinea Pig Tumor 090178R
80/10
Guinea Pig Tumor 081878RC
80/11
Guinea Pig Tumor 072878R
80/12
Guinea Pig Tumor 063078R
80/13
Guinea Pig Tumor 122878R
80/14
Guinea Pig Tumor 100777R
80/15
Guinea Pig Tumor 072277R
80/16
Guinea Pig Tumor 040877R
80/17
Guinea Pig Tumor 101576-I Cantrell
80/18
Guinea Pig Tumor 052076R
80/19
Guinea Pig Tumor 051376R
80/20
Guinea Pig Tumor 042176R
80/21
Guinea Pig Tumor 012876R
80/22
Guinea Pig Tumor 122475R
80/23
Guinea Pig Tumor 121175R
80/24
Guinea Pig Tumor 120375R
80/25
Guinea Pig Tumor 103075R
80/26
Guinea Pig Tumor 100275R
80/27
Guinea Pig Tumor 092475R
80/28
Guinea Pig Tumor 082075R
80/29
Guinea Pig Tumor 081275R
80/30
Guinea Pig Tumor 072575R
80/31
Guinea Pig Tumor 071775R
80/32
Guinea Pig Tumor Experiment 070975R
80/33
Guinea Pig Tumor Experiment 070375R
80/34
Guinea Pig Tumor 060575R
80/35
Guinea Pig Tumor 052375R
80/36
Guinea Pig Tumor 050775R
80/37
Guinea Pig Tumor 041675R
80/38
Guinea Pig Tumor 040375R
80/39
Guinea Pig Tumor 022775R
80/40
Guinea Pig Tumor 0214759
80/41
Guinea Pig Tumor 020575R
80/42
Guinea Pig Tumor Experiment 012275R
80/43
Guinea Pig Tumor 011674 $
80/44
Guinea Pig Tumor 010275R
80/45
Guinea Pig Tumor 122074R
81/1
Guinea Pig Tumor Experiment 121974R
81/2
Guinea Pig Tumor121174R
81/3
Guinea Pig Tumor 120374R
81/4
Guinea Pig Tumor Experiment 112974 $
81/5
Guinea Pig Tumor 111974R
81/6
Guinea Pig Tumor 110674R
81/7
Guinea Pig Tumor 102374R
81/8
Guinea Pig Tumor Experiment 101674R
81/9
Guinea Pig Tumor Experiment 100174R
81/10
Guinea Pig Tumor Experiment 092474R
81/11
Guinea Pig Tumor Experiment 090574R
81/12
Guinea Pig Tumor Experiment 082274R
81/13
Guinea Pig Tumor Females Experiment 082074 $
81/14
Guinea Pig Tumor 072974R
81/15
Guinea Pig Tumor 071874R
81/16
Guinea Pig Tumor 071174R
81/17
Guinea Pig Tumor 070274R
81/18
Guinea Pig Tumor Experiment 062774R
81/19
Guinea Pig Tumor 060574R
81/20
Guinea Pig Tumor 050374 $
81/21
Guinea Pig Tumor 051674R
81/22
Guinea Pig Tumor 050874R
81/23
Guinea Pig Tumor 050274 $
81/24
Guinea Pig Tumor Experiment 042574 $
81/25
Guinea Pig Tumor 042274R
81/26
Guinea Pig Tumor Experiment 040174R
81/27
Guinea Pig Tumor 032074 $, L10, TC's, T. Spiralis- Granger
81/28
Guinea Pig Tumor Experiment 031574 $
81/29
Guinea Pig Tumor 022274R
81/30
Guinea Pig Tumor Experiment 022174 $
81/31
Guinea Pig Tumor Experiment 021274 $
81/32
Guinea Pig Tumor Experiment 020574 $
81/33
37RV on L10 Guinea Pig T 02-1974
81/34
Guinea Pig Tumor Experiment 010374 $
81/35
Guinea Pig Tumor Experiment 012274R
81/36
Guinea Pig Tumor Experiment 010874 $
81/37
Guinea Pig Tumor Pt.1 Experiment 122173, Pt.2 Experiment 122773
81/38
Guinea Pig Tumor Experiment 122173 TG 041675
81/39
Guinea Pig Tumor Experiment 120773R
81/40
Guinea Pig Tumor Experiment 120573R
81/41
Guinea Pig Tumor Experiment 110973 TG Brehmer
81/42
Guinea Pig Tumor Experiment 091973R
81/43
Guinea Pig Tumor 091873
81/44
Guinea Pig Tumor 091173R
81/45
Guinea Pig Tumor Male/Female 082373
82/1
Guinea Pig Tumor Female Experiment 070373
82/2
Guinea Pig Tumor Male 071173
82/3
Guinea Pig Tumor Experiment 061273
82/4
Guinea Pig Tumor Female Experiment 052473
82/5
Guinea Pig Tumor Male Experiment 050273
82/6
Guinea Pig Tumor Experiment 041173 Hartley
82/7
Guinea Pig Tumor Male Experiment 040473
82/8
Guinea Pig Tumor Male Experiment 031273
82/9
Guinea Pig Tumor Female Pt.1 021373, Pt.2 022273
82/10
Guinea Pig Tumor Female Experiment Experiment 020273
82/11
Guinea Pig Tumor Male 010273
82/12
Guinea Pig Tumor Male 121172
82/13
Guinea Pig Tumor Male 101672
82/14
Guinea Pig Tumor 101072
82/15
Guinea Pig Tumor Male 103172
82/16
Guinea Pig Tumor Female 081472
82/17
Guinea Pig Tumor Female 081072
82/18
Guinea Pig Tumor Female 072972
82/19
Guinea Pig Tumor 072672 To Be Challenged
82/20
Guinea Pig Tumor Female 062872
82/21
Guinea Pig Tumor Male 062872
82/22
Guinea Pig Tumor Female/Male 051872
82/23
Bethesda Tumor Experiment 042572
82/24
Guinea Pig Tumor 031472 II
82/25
Guinea Pig Tumor 031472 I
82/26
Guinea Pig Tumor 020372 BCG-115, BCG-102
82/27
Guinea Pig Tumor Summary Data
82/28
Proposed Tumor Experiments
83/1
University At Bern Russian Language Document
83/2
University at Bern Quantitative Analyse
83/3
University at Bern Chitin
83/4
University at Bern Notebooks
[1940-1949]
83/5
University at Bern Notebooks
83/6
University at Bern Notebooks
83/7
University at Bern College Papers/Notes
84/1
University at Bern Augszug der Organischen Chemie I
84/2
University at Bern Electron Microscope 1940's
84/3
University at Bern Swiss Scientists Assn
84/4
University at Bern Bericht NR.5 (e)
84/5
University at Bern Bericht NR.4 (d)
84/6
University at Bern Bericht NR.6 (c)
84/7
University at Bern MN-AL Dopplehydroxide und Bas. Dopplechlorid (b)
84/8
University at Bern Papers (a of the sequence)
84/9
University at Bern Physical Chemie 77282 K 7.50
84/10
University at Bern Einfuring in die Qualitative Analyse
84/11
University at Bern Pharmazeutischer Analysen Allgemeines, Lituratur
85/1
University at Bern Mss. Manuscripts, Notes
85/2
University at Bern Biochemische Gesellschaft
85/3
University at Bern Cellulose Industries
85/4
University at Bern Oganische Chemie Vorlesung
85/5
University at Bern Differential U. Itegralrechnung
85/6
University at Bern Mineralogie
85/7
University at Bern Licht und Materie
86/1
University at Bern Dr. W. Feitknecht, Chemikerfachverein der Universitat Bern
86/2
University at Bern Eletorchemie Ribi IV
86/3
University at Bern Augszug der Organischer Chemie Ribi III
86/4
University at Bern Phsikklausur Ribi Pt.1
86/5
University at Bern Phsikklausur Ribi Pt.2
86/6
University at Bern Phsikklausur Ribi Pt.3
86/7
University at Bern Phsikklausur Ribi Pt.4
86/8
Universitat Bern Phsikkluasur Botanik Pt.5
86/9
University at Bern Cellulose Meetings
87/1
Electron Microscope
87/2
Phillips Experiment M Documents
87/3
Charts and Graphs for Schematics
87/4
Mechanical Drawings (B)
87/5
Mechanical Drawings (A)
87/6
Mechanical Drawings
87/7
Mechanical Drawings
87/8
Experiment M Studies of Rayon, Manuscripts
87/9
Electron Diffraction
88/1
Collaborations Larson Experiment
88/2
Collaborations Perrine Project
88/3
Collaborations Jim Simmons
88/4
Collaborations Jim Simmons Running Experiments
88/5
Collaborations Jim Simmons
1968
88/6
Collaborations Takayama, ET MS's No. 1
88/7
Collaborations U.S.-Japan, Program, Letters, Miscellaneous
88/8
Collaborations U.S.-Japan, Program, Letters, Miscellaneous
89/1
Collaborations Galanos Fractionation "1.03gr Lipid "A"
89/2
Collaborations J. U. Gutterman, M.D., University of Texas Literature
89/3
Collaborations D.L. Granger, Reports, Correspondence, Etc
89/4
Collaborations J.H. Hanks, Reports, Correspondence, Etc
89/5
Collaborations Hazelton Monkey Experiment 1 MS. May
1971
89/6
Collaborations Hazelton Monkey Necropsy Rpts
89/7
Collaborations L.B. Hinshaw, Ph.D. Reports Correspondence, Etc
89/8
Collaborations Hollister-Stier, Ragweed
89/9
Collaborations Dr. Kon Hwang, Reports Correspondence, Etc
89/10
Collaborations Key/Kuni B4, B4-4.5Ph, B4-HcL Data
89/11
Collaborations Kuni ACP
1978-1980
89/12
Collaborations Kuni Endotoxin Fractionation MS Reports
1980
89/13
Collaborations Kuni Early MCP Fractionation
89/14
Collaborations Kuni Lipid "A" Frations "1.14
90/1
Antigens-H.Caps; Immu. Props of Protplasm v. CW's
90/2
Distribution of Bacteria in Antigens
90/3
Amino Acids Analysis Results
90/4
Disruption of Bacteria for Preparation of Antigens, CW's
90/5
Arabinose Mycolate Research
90/6
Ultrastruct. - Enveloping Spores in B.Ceres
90/7
Batch Cultures No. 1 - No. 92
90/8
Batch Cultures No. 93- No. 185
90/9
Batch Cultures No. 186- No. 251
90/10
Batch Cultures No. 252- No. 283
91/1
Bed Processing, Microparticulate Silica
91/2
New Bed Processing, Micro. Silica
91/3
Antigens of Bordetella Pertussis
91/4
BCG-Rickettesial Infections, H.E.W. memos
91/5
BCG- CW Vaccine, T-S
91/6
BCG Production Yields
91/7
Preparationof Cell Wall Skeletons From BCG
91/8
BCG Misplaced
91/9
BCG Treatment of Melanoma
91/10
BCG Experiment's
91/11
Bioassays Composite
91/12
Canine Mammary, others
91/13
Canine Distemper, Measles, SSPE, Photos; NMS Society
91/14
Preparation for CW Vaccine
91/15
Cell Wall Organization of Plants
91/16
Charted Data
91/17
Column Experiment's Book 1
92/1
Demonstration
92/2
EDTA Treatment
1979-1980
92/3
ExperimentMycobat Btol. 322
10
92/4
Endotoxins Proposed
92/5
Reaction - Endotoxins and Surfactants
1966
92/6
Reaction - Endotoxins and Suractants
1966
92/7
Reaction - Endotoxins and Suractants
1966
92/8
Physical Aspects of Rev. Inactiv. of Endotoxins
92/9
EAExperiment Experiment
December 1974
92/10
Extract.and Puri. of Endotoxins from Enterobacteridceae
92/11
Reaction Endotoxins and Suractants I. Physical and Biochemical Props
92/12
New Attempt at Peptide Free Endotoxins
1964
92/13
Preparationof Micororganisms for Electron Microscope
92/13a
Electron Microscope Preps
1978
92/13b
Electron Microscope Exp's
1979
92/14
Origin/Properties of Naturally Occuring Hapten
92/15
Orgin/Properties of Naturally Occuring Hapten
92/16
Physical Structure of Native Hapten
92/17
Orgin/Properties of Naturally Occuring Hapten
93/1
Progress Reports
1977
93/2
Progress Reports
1979, 1980
93/3
Progress Reports
1976
93/4
Progress Reports
1974, 1975
93/5
Progress Reports RML
1974
93/6
Progress Reports
1973
93/7
Progress Reports
1972
93/8
Progress Reports RML
1970, 1971
93/9
Progress Reports SIE Tuberculosis
1971
94/1
Progress Reports
1970
94/2
Progress Reports Advisory Counsel
1970
94/3
Progress Reports
1969
94/4
Progress Reports
1968
94/5
Progress Reports
1966, 1967
94/6
Progress Reports RML Tuberculosis
1966
94/7
Progress Reports
1966
94/8
Progress Reports
1964
95/1
Progress Reports
1963
95/2
Progress Reports
1962
95/3
Progress Reports
1961
95/4
Progress Reports
1960
95/5
Progress Reports
1959
95/6
Progress Reports
1959
95/7
Progress Reports
1958
95/8
Progress Reports
1957
95/9
Progress Reports
1956
95/10
Progress Reports
1955
95/11
Progress Reports No Date
95/12
Progress Reports
1953
95/13
Progress Reports DCCP
96/1
Tuberculosis Research Committee
September 1969
96/2
Tuberculosis Statistical Analysis
96/3
Tuberculosis Statistics
96/4
Tuberculosis Abstracts, Reprints, and Correspondence
96/5
Tuberculosis Abstracts, Reprints, and Correspondence
96/6
Tuberculosis Correspondence
96/7
Tuberculosis Mouse Protection Tests
1964
96/8
Tuberculosis Mouse Protection Experiment BCG-77
November 1964
96/9
Tuberculosis Mouse Protection Experiment BCG-81
November 1964
96/10
Tuberculosis Mouse Protection Experiment BCG-80
September 1964
96/11
Tuberculosis Mouse Protection Experiment BCG-79
June 1964
96/12
Tuberculosis Mouse Protection Experiment BCG-76
June 1976
96/13
Tuberculosis Mouse Protection Experiment BCG-78 I, II, III
May 1964
96/14
Tuberculosis Mouse Protection Experiment BCG-78 I
May, June 1964
96/15
Tuberculosis Mouse Protection Experiment BCG-69
97/1
Tuberculosis Mouse Toxicity
97/2
Tuberculosis Methanol Extract, Negre; , Lembke
97/3
Tuberculosis
97/4
Tuberculosis Hypersensitivity H.E.W
97/5
Tuberculosis Resistance Stim'd by Fractions from Attenoated Tuberculosis
97/6
Tuberculosis Skin Reactions in Rabbits
97/7
Tuberculosis Skin Tests, Tuberculin, ppd
97/8
Tuberculosis Skin Test Results
8-24-1960
97/9
Tuberculosis Spec. Resistance to Tuberculosis and Salmonella in Mice by Oil CW's
97/10
Tuberculosis 88 Test, 2112 Rabbits
1976
97/11
Tuberculosis Rabbit Skin Test
97/12
Tuberculosis Research Committee
September 1969
97/13
Tuberculosis Youman's Literature
97/14
Tuberculosis Bad Publicity
98/1
Tuberculosis Experiment Tables
99/1
Antigens of Histoplasma Caps I
99/2
Glass Knives for Thin Sec. Microtomy
99/3
Granuloma Protection
1970-1974
99/4
Gran. Prot.
1970-1974
99/5
Gran. Prot.
1970-1974
99/6
Lactobaccilus Bifidus
99/7
Leprosy
99/8
Line 10 Tumor Regression Experiment Dosing
99/9
Line 10 Mss
99/10
Line 10 Tumor I
100/1
Spectrophometric Det. of Fatty Acids Amides in Lipids
100/2
Lipid Studies
100/3
Lipids, Toxins
100/4
Neutral Lipids Book No. 1
100/5
B4- Lipid "A" 100
100/6
Metabolic Effect of L."A" In Vitro Tox., Proposed
100/7
LMSF Notes, Ribi
100/8
Marijuana Literature, Chromo., Etc
100/9
Marijuana
100/10
Marijuana II, Mex. Male
100/11
Marijuana I, Mex. Female
100/12
Media
100/13
Methodology Manual-Mycobacterial/Fungal Antigens
100/14
Immu. Sign. of CW of Microbact
100/15
Mss. Lit
101/1
RandD Planning
101/2
RandD Planning
101/3
F.D.A
101/4
Publicity, Tumor Immunity
101/5
Products
101/6
Patent Material
101/7
Patent Matters
101/8
Notes, Laser Correspondence
101/9
BitterRoot Med. REs. Inst
101/10
Suggestions - Hans
101/11
Sorval-Ribi Abstracts
101/12
Ribi Intra-Co. Memos
101/13
Ribi Immu. RandD, Wheat and Takayama
1983
101/14
Structure/Function Relationship of Bacteria Endotoxins
102/1
Correspondence
102/2
Correspondence
102/3
Correspondence Veteran's Administration
102/4
Correspondence Mt. Trudeau Soc., Mt. Lung Association
102/5
Correspondence
1959
102/6
Correspondence
1961
102/7
Correspondence
1960
102/8
Correspondence
1963
102/9
Correspondence
1962
102/10
Correspondence
1964
102/11
Correspondence
1965
102/12
Correspondence Walker, Department of Environmental Science, Hobby-H.E.W
103/1
Endotoxins Literature/Correspondence
103/2
Correspondence
103/3
Correspondence Microbio. Assn's, Tests and Results
103/4
Correspondence
103/5
Correspondence
103/6
Correspondence
103/7
NTA/MTA Abstracts, Other
103/8
Correspondence, Reports, Contract No. NIH-NIAID 73-2513-P3
103/9
Munich - Borstel Correspondence, Manu's
1965
103/10
Mss. Correspondence
103/11
Helen File, Correspondence, Memos
103/12
Hans Ribi, Cell Wall Skeletons, TDM, MPL, (Tir-Mix 2,3)
103/13
TNI
103/14
Personal Notes
103/15
Monthly Progress Reports other than E.R., Prod. Devel
103/16
Developments in Immunization Agents in Mal. and Infectious Disease
104/17
NIAID Highlights of the Week
103/18
Friday Sessions R and R
103/19
Ribi Incorporated, Reprints
103/20
Lab Planning
104/1
Miscellaneous Papers/Notess
104/2
The Mycobacterial Source Book
104/3
Mycrobacterial Cell Wall Fraction Immunostimulant
1984
104/4
Use of Press. Cell for prep of CW's of Mycobacteria
104/5
Nitrogen
104/6
Nitrogen
104/7
Pasteurella Pestis
1958
104/8
Studies-Fine Structure of Penicillium Chrysogenum
104/9
Phosphorus
104/10
Phosphorus
104/11
Pollen Fractionation
1957
104/12
Prostaglandins
104/13
739 and up Protodyne Notes
105/1
Notes to PP to Conicals
105/2
P3 Isolation
105/2a
P3, B4
1981
105/3
Pyrogen Tests
105/4
Q-Fever Project
105/5
New Method for Purification of Q-Fever/Rickettesia
105/6
Experiment Results
105/7
Experiment Results
105/8
Experiment Results
105/9
Experiment Results
105/10
Experiment Results
105/11
Experiment Results
105/12
Experiment Results
105/13
Bacterial Ribosomes
105/14
Studies- Antigens on Salmonella
106/1
Physical and Chemical Anal. of EXT of Salmonella Enterit
106/2
Sep. and Immunization Sign of Antigens From Salmonella, SAB
1956
106/3
Antigens of Sal. I., Immunization Props. Protoplasm v. CW's
106/4
Steroids
106/5
Steroids
106/6
Steroids
106/7
Sterility and Toxicity Tests, F.D.A
106/8
Toxicity Data Sheets
1956-1958
106/9
Toxicity Data Sheets
1959-1960
106/10
Toxicity Data Sheets
1961, 1962
106/11
Toxicity Data Sheets
1963, 1964, 1965
106/12
Tables
107/1
Trehalose Dimycolate Research
107/2
Experiment Mycobat Morph.- B.Tularense, Growth Cycle IV, Liquid Media
107/3
Effective Non-Living Vaccine Preparations of M.S
107/4
Tumor Experiment
107/5
Tumor Experiment
107/6
Vaccine Experiment Results
107/7
Physics of Viruses
107/8
X-Ray Diffraction Lecture Course

Series IV:  Speeches and Writings:, 1954-1986Return to Top

13.0 linear feet

This series contains a mixture of draft and published materials for which Edgar Ribi was either a primary of contributing author regarding issues of immunology and infectious disease research. Materials in this series primarily date from the years of Ribi's work for the National Institutes of Health and include articles, symposium display text, scientific panel presentations, and speeches.

Container(s) Description Dates
Box/Folder
108/1
Abstracts
undated
108/2
Titrating Endotoxic Activity on Rabbits
undated
108/3
New Immunization Clin. Apps., Monophos.Lipid "A" Detox ENX
undated
108/4
Immunization of Rab. with CW's from BCG against Tuberculosis
undated
108/5
Progress Report, Pers. Evaluation of Centirchrome
undated
108/6
Purification of Q-Fever, Rickettesiae
undated
108/7
Short Syncrytization of Adjuvant Dipeptide (MDP)
undated
108/8
Antigens in T.A. Hemaggl. in Myco. Tuberculosis
undated
108/9
Anti-Myco Immunization in Rhesus with BCG/Aeresol with M.Tuberculosis
undated
108/10
ACS Meeting Atlanta, Ga
undated
108/11
Act. Guinea Pig Macro by CW's of M. Bovis BCG
undated
108/12
Act. Guinea Pig Macro by Q-Fever Rickettesiae
undated
108/13
Activity of Tre.Dim. from M. Species with M. Dipeptide
undated
108/14
Administration BCG-Cell Wall Skeletons into Mal.Effus.,ToxicandTherapy Effects
undated
108/15
Advisory Council Meeting
undated
108/16
Aerogenic V. with BCG against Tuberculosis In Monkeys - Mulatta
undated
108/17
Aero induced Tuberculosis in Monkeys after I.V. BCG Vaccination
undated
108/18
All Encephalomyelitis Studies for Symposium Presentation
undated
108/19
Alteration of Physical Chemical Biological Properties of ENX with Alkali
undated
108/20
Experiment Model for Immunizationof Cancer
undated
108/21
Non-living Vaccine against Exp Tuberculosis in Mice
undated
108/22
Annual Meet of A.S.C.R., Washington, D.C.
1981
108/23
Antigen Reactive Properties of Fract. of Coxiella Burnetii
undated
108/24
Antigens from CW of S. Enteritidis, Separation, Activity
undated
109/1
Antigens from CW's of Sal. Typhosa
undated
109/2
Antigens of Yeast of Histo Caps., I, Morpho. by Electron Microscope
undated
109/3
Antigens of Yeast of Histo Caps., II, Immunization Properties of PP v CW
undated
109/4
Antigens of B. Pertusis, Activty of CW, PP
undated
109/5
AntiTumor of Detoxed ENT
undated
109/6
App. of Cen. Chrom. in Arthopod Hemolymph, Tissue,etc.
undated
109/7
1st ASM Conference on Biotech. Abs., Ribi
1986
109/8
ASM
1962
109/9
ASM
1963
109/10
ASM Audience List
1963
109/11
ASM
1964
109/12
ASM
1965
109/13
ASM
1971
109/14
ASM
1972
109/15
ASM
1974
109/16
ASM
1975
109/17
BCG-CW Immunization of Intramus/Metast. M.Rat Heptomas
undated
109/18
Bacteria ENT: v.3 Chap. 1
undated
109/19
Bacteria ENT Scavenger-Reception on Human Mono-Macrophages
undated
109/20
Effect of Bacteria ENT on Human Adenovirus
undated
109/21
Mikroorgan. die Immunizationdes Krebses
undated
109/22
Benefitial Modification of ENT Molecule
undated
109/23
BCG CW Components in T Supp. and Regression
undated
109/24
BCG Cell Wall Skeletons, P3, MDP, and Micro. Comp./Structure in Animals
undated
110/1
Berlin
undated
110/2
Bibliography
undated
110/3
Big Sky U.S.-Japan
1975
110/4
Biological/Chemical Characteristics of this Batch ENT in Shock Tour
undated
110/5
Mycobact. (M) CW's, Isolation/Comp.-Cell Wall Skeletons, P3
undated
110/6
M CW's, II Supp./Regr. S.2 Heptoma
undated
110/7
M CW's, III Experiment Enceph. in Guinea Pig
undated
110/8
M CW's, IV Prot. Mice of Myco. Tuberculosis
undated
110/9
M CW's, V Granular Formation in Mice and Guinea Pig
undated
110/10
Pt.1, Mycobat CW's v. Granular Formation in Mice and Guinea Pig
undated
110/11
Pt 2, Mycobat CW's v. Granular Formation in Mice and Guinea Pig
undated
110/12
VI BCG CW in Saline with BCG Oil Vaccine
undated
110/13
Monophosphoryl Lipid "A"
undated
110/14
P. ENT and Lipid Fract. W/Acid-Hyd. ENT
undated
110/15
Biophysical Society, Prog. and Abs.
1959
110/16
BioTech. Development in Bacteria Vaccine Production Conference
1965
111/1
Borstel Colloquium, May
1963
111/2
B4, ACP, Fract., Abs. for 16th Annual Tuberculosis Conference
undated
111/3
Cancer Immunization with Non-living Mycobacts. Comps.
undated
111/4
Cell RandR Inves. W/Sorvall RF-1, Ribi Ref. Cell Fract.
undated
111/5
CW's BCG as Vaccines for Myco. Legrae in Mice (32729)
undated
111/6
Centrifugal Chromotography
undated
111/7
Centrifugal Chromotography of Cannab. Through Microparticulate Silica
undated
111/8
Centrifugal Chromotography of Myco. Lipids
undated
111/9
Centrifugal Chromotography of Micropart. Bed Chromo. of Lipids
undated
111/10
Comparisions of ENT's of Enterobacteriacena
undated
111/11
Investigation on Fract. from Aqueous Ragweed Pollen
undated
111/12
Props of Proteus L. Forms and Parent Forms
undated
111/13
Props of Bacteria L. and Parent Forms
undated
111/14
ENT, I, Prep of ENT with Minimal Lipid Content
undated
111/15
ENT, II, Lipodal Fract. v. Parent ENT
undated
111/16
ENT, III, Kinetic Study of Acid Hydrolosis of ENT
undated
111/17
M CW's, Immunizationto Airborne M. Tuberculosis H37RV
undated
111/18
Chemically Defined Adjuvants of Bacterial Origin
undated
112/1
Chemistry Panel, Institute Pastuer
1963
112/2
Chemotaxogenic and Tumor Regression Glycol, Mclaughlin
undated
112/3
Centri-Chromo of Microbial Lipids in Micropart. Gel
undated
112/4
Centri-Chromo of Mycobacterial Lipids in M. Gel
undated
112/5
Centri-Chromo of Steroids in M. Gel
undated
112/6
Centri-Chromo Separation of Myco. Lipids
undated
112/7
Centri-Chromo Separation of Steroids in Col.'s of Microp. Silica
undated
112/8
Clinical Immunization Newsletter
undated
112/9
1 Committee on Ragweed Pollen Antigens
1963
112/10
2 Committee on Ragweed Pollen Antigens
1963
112/11
Comp. of Myco., Induct of Cell Mediated Immunizationin Mice
undated
112/12
Conference on ENT in Immunization Freiburg 1959, Ribi Self Portrait
undated
112/13
Conference on ENT, Bryn Mawr
1961
112/14
Conference on ENT, Fla.
1963
112/15
Conference on ENT, Pt.1, Houston
1977
113/1
Conference on ENT, Pt.2, Houston
1977
113/2
Conv. of Antigens of C. Burnetti to Hapten by Phenol
undated
113/3
Microbial Agents and Their Biological Properties
undated
113/4
Cross Reactive AGN, Houston
1977
113/5
Current Tuberculosis Research
undated
113/6
Cutaneous Gran. Resp. to BCG CW's in Cancer Immunization
undated
113/7
Delayed Hypersensitivity to Protein in M. Glycolipid
undated
113/8
Skin Reaction in Guinea Pig byMycobat Tuberculosis, etc. Group II Fast Acids
undated
113/9
Determination of Heptose in ENT
undated
113/10
Determination of Impuritites in TDM by Liav/Ribi
undated
113/11
Chromotography Developement
undated
113/12
Dif. Req. for ENT Glycolipid for T Regression ENT Activity
undated
113/13
Disruption/Isolation of Bacteria/Antigens for Anti-Tuberculosis Vaccine
undated
113/14
Disruption of Bacteria and Preparation of CW's
undated
113/15
Disruption of Bacteria and Isolation of AGN
undated
113/16
Doc's-US Delegation Meeting, Pgs. 0-61
1975
113/17
Doc's-US Delegation Meeting, Pgs. 62-123
1975
113/18
Protocol for Experiment I at NCPB, University of California at Davis
undated
113/19
Duration of Immunization to Tuberculosis in Mice with Myco.Bovis BCG
undated
113/20
Early Phase ENT Tolerance: by DTX Lipid "A", Monophos. A
undated
113/21
Ribi, Manuscripts
1954-1958
113/22
ACTH-Rabbit Adrenal, Cytochrome P450, Protein Elec-phos
undated
113/23
BCG CW's on Meta. Potential of Trans. Morris Heptoma
undated
113/24
Monophosphoryl Lipid"A" on Host Resistance to Bacteria
undated
113/25
S. EDS ENT-Lipid"A" on Dermal Reactivity to Epinephr.
undated
113/26
Syn. and Nat. Trehalose, Fatty Acid Esters in T Regress.
undated
114/1
BCG, Myco. and MDP on Resistance to Aero. Influ. Virus
undated
114/2
Nontox Lipid "A" and ENT on Resist to Toxoplasma Gondii
undated
114/3
Pretreat Mice with BCG in Saline on Subsequent Vaccine
undated
114/5
Nonliving Vaccine v. Experiment Tuberculosis in Mice
undated
114/6
M. Bovis BCG v. Pulmonary Inf. of Mycobat Tuberculosis H37RV
undated
114/7
BCG CW-Syn. Hydrocarbon v. Experiment Tuberculosis in Mice
undated
114/8
Various Mycobat CW's v. Tb in Mice
undated
114/9
M CW's BCG v. Airborne Tuberculosis in Subhuman Primates
undated
114/10
T Cell Extracts in Immunoth. of Murine EL-4 Luekemia
undated
114/11
Experiment Tuberculosis in Mice (Swiss)
undated
114/12
Electron Miocroscope (Swiss)
undated
114/13
Electron Microscope, X-Ray Studies on Superpolyamidfaden (Swiss)
undated
114/14
Electron Microscope CW Organization of Plants
undated
114/15
Electron Microscope CW Organization of Wood
undated
114/16
Electron Microscope Morph. of B. Tularense in Liquid Media
undated
114/17
Electron Microscope Morph. of Bacteria, Relation to Immunizationof Experiment Infection
undated
114/18
Electron Microscope of B. Tularense and in vitro/vivo Immunization Reactions
undated
114/19
Electron Microscope CW's of B. Tularense and Relation to Immunization Functions
undated
114/20
Employees List, Phone No.'s
undated
114/21
ENT and Antigens Fract. from CW S. EDS, Bio. Activity
undated
114/22
ENT Extracts in Immunizationof Guinea Pig Line 10 T
undated
114/23
ENT: Perspective of Structure
undated
114/24
ENT Aspects in Relation to Biological Activity
undated
114/25
ENT Receptors in Heptocellular Carcinomas, Mclaughlin
undated
114/26
ENT Seminars, Bethesda
1961
114/27
Enhancement of Anti T Resistance, Ribi et. al.
undated
115/1
Enhancement of Anti T Resistance by Myco. Prods. and ENT
undated
115/2
Enhancement of Chemiluminescence and Phagocytic Activity by Lipid A
undated
115/3
Enhancement of ENT Shock by MDP
undated
115/4
Enhancement of ENT Shock by Diff. MDP Composition
undated
115/5
Enhancement of Immunization Response by Syn Activity of Nontox Lipid A, Mycobat CW
undated
115/6
Enhancement of Macro. Mediated T Cell Killing by Bact. Mem. Prot.
undated
115/7
Enhancement of T Activity by Bacteria Adjuvants
undated
115/8
Enhancement to Resist Tuberculosis by Purified Myco. Lipid Fract.
undated
115/9
Enhancement of T Immunizationby Monophosphoryl Lipid "A"
undated
115/10
Enzymes from E. Coli by Sorvall Cell Fractionator
undated
115/11
Eradication by Myco. Vaccine and T Cell of Micro Metas's
undated
115/12
Erad. Lymph Node Matas. after Injection of ENT/Myco Comps.
undated
115/13
Extract/Purification of ENT from Enterobact., Comparisons
undated
115/14
Factors Prot. Against Experiment Tuberculosis by Heat Stable CW Vaccine
undated
115/15
FASB Atlantic City
1972
115/16
Electron Microscope, X-Ray Difract. of Histo. Capsulatim
undated
115/17
Footpad Sensitivity/Resist by Vaccine of Myco. CW
undated
115/18
Fract. of M. bovis BCG
undated
115/19
Fract. of Mycobact.
undated
115/20
Centri-Chromo Fract. of Wax "D" in Micro Parts
undated
115/21
Occurance of Nat. Haptenin Enterbacteriological Sp.
undated
115/22
Structure Recs. for Agent of IMM. in Guinea Pig Line 10 T
undated
115/23
Glucan: 5 Syngeneic Tumors in Guinea Pig and Mice
undated
115/24
Harnessing the Beneficial Effects of ENT
undated
115/25
Harvesting and Disintegration
undated
115/26
Hexoamines, Notes, Cancers
undated
116/1
Host Reative Props. of Myco, Comps. in Anti T Immunization
undated
116/2
Hybird Formation Between Bacterial ENT
undated
116/3
Immunization Prophlaxis of Myco. Infections
undated
116/4
Immunization Responses in R. Monkeys with BCG, Aerosol-M Tuberculosis
undated
116/5
Immunization of Mice Vaccinated with BCG CW's
undated
116/6
Immunization of Rabbits with Viable BCG and CW Vaccine
undated
116/7
Immunization of Mice by Inactive Fract. of M. Bovis BCG
undated
116/8
Immbio. Activity of Nontoxic Lipid "A"
undated
116/9
Immunization of Mycobat CW Experiment to Airborne Tuberculosis in Mice (Swiss)
undated
116/10
Immunization of CW from Myco.s to Airborne Tuberculosis in Mice
undated
116/11
Immunization of CW from M. Lepraemurium to Airborne Tuberculosis
undated
116/12
Immunization Approaches to Human Cancer by Guinea Pig Model
undated
116/13
Immunization Prop. of Proto v. CW, New Isolation of ENT
undated
116/14
Immunization Signifigance of CW of Mycobacteria
undated
116/15
Immunization Props. of CW v. Proto. from Mycobacteria
undated
116/16
Immunization Role of Brucella Abortus CW's
undated
116/17
Immunization Potentiating Activity of Monophosphoryl Lipid "A"
undated
116/18
Immunization BCG With Myco. Fract. in Lung Cancer (Swiss)
undated
116/19
Immunization for T with Microbial Contents or Syn. Analogues
undated
116/20
Immunization of Guinea Pig Heptoma with living BCG
undated
116/21
Immunization of Bovine Neoplasms with Cell Wall Skeletons, TDM, MPL, CY
undated
116/22
Immunization of Bovine Squamous Carcinoma with Cell Wall Skeletons, TDM
undated
116/23
Immunization of Cancer Regss. of Intrad. T in Intral. Inj. MCW
undated
116/24
Immunization of Cancer T Supr./Rgrss.by CW of Mycobat Phlei in Oil
undated
116/25
Immunization of Equine Sarcoid with Cell Wall Skeletons TDM Biologic
undated
116/26
Immunization of Occ. Squam. Cell Carci. in Cattle with Myco.B.
undated
116/27
Immunization of Antigen Intramus.T and Pulmon. Metas. by BCG CW
undated
116/28
Immunization of Nonviable Micro. Comps.
undated
116/29
Inactivity of ENT with Bile Salt, Human Plasma Comp.
undated
116/30
Induction of Resistance to Tuberculosis in Mice with Myco., unrelated
undated
117/1
Inf. Dis. Soc. of Am. Presented at 8th Ann.
1970
117/2
Fine Lipid "A" on Limulus Amebocyte Lysate, and Toxics
undated
117/3
Fine Lipid "A" to its Limulus A.L. Clots, and T Rgrss.
undated
117/4
Inhib. Pul. Gran. by Myco. Proto and Immsup. to Mycobat Tuberculosis
undated
117/5
Int. Conference of Immun, Pharmacy (2d), Wash. D.C.
1982
117/6
Int. Symposium, on Immu. of Cancer, Prog. Abs, etc.
1985
117/7
Intrales Immunization of M. Melanoma by M. Smegmatis Cell Wall Skeletons TDP3
undated
117/9
Intra T Chemical Immunization by MitocinC and Mycobat in Rgrss.of Line 10 T
undated
117/10
Phaze I, II of Intra T Immunization with BCG Cell Wall Skeletons plus P3
undated
118/1
Isolation and Composition of P3
undated
118/2
Isolation of Nontox Lipid "A" Fract. with T Rgrss. Activity
undated
118/3
Isolation Immunization Toxic Comps from Cord Factor Mycobat Tuberculosis Auyama B
undated
118/4
Isolation of Biol. Act. Comps of Myco. CW, Strain 2 Guinea Pig Hept.
undated
118/5
KDO, never published
undated
118/6
Landy Invite List Program, etc.
1965
118/7
Lipid "A" and Immunotherapy
undated
118/8
Localand Systematic Immunization of Human Cancer byMycobat Cell Wall Skeletons, TDP3
undated
118/9
MAAF, Notes R.S., N.S.
undated
118/10
Malginant Effusions Phase I, II Richman
1979
118/11
Migrat. Inhibit. Study of M. Bovis BCG, Relationships
undated
118/12
Manuscript, Electron Microscope Morph. of B. Tularense, during Growth in Liquid
undated
118/13
Manuscript, Electron Microscope, X-Ray on Superpolymide Fibers
undated
118/14
Manuscript, Fine Structure of Cellulose Experiment
1950
118/15
Manuscript, Fine Structure of Rayon, Arkev fur Kemi
1950
118/16
Manuscript, - --,---, Activity of ENT, 3Mss-2Mss
undated
118/17
Manuscript, Submicro. Structure of Fibers and Formation
1981
118/18
Manuscript, Electron Microscope Struct of B. Tularense, in vitro/vivos in Immunization
undated
118/19
Manuscript, Disruption of Bacteria, Stockholm Conference
undated
118/20
Manuscript, Bacteria AGN, Disc.of Bacteria prep of CW, GalliProof
undated
118/21
Manuscript, Factors Infl. Protection Against Experiment Tuberculosis
undated
119/1
Manuscript, Reaction of ENT and Surfacants
1966
119/2
Marijuana: ID of Cannab. by CC
undated
119/3
Measure of Antibact. Immunization Stim.dby O ANG, S. Typhosa
undated
119/4
Mech/Struct Req of BCG CW for Syn.T Rgrsswith ENT Gly
undated
119/5
FASEB Meeting, Chicago
1983
119/6
FASEB Meeting, Atlantic City
1972
119/7
Mt. Tuberculosis Assn. Helena
1968
119/8
Seminar in GTF
1973
119/9
Meeting of US Delegation
1976
119/10
Meeting of US Delegation
1976
119/11
12th Meeting of US-Japan Cooperation Medical Science Committee
1976
119/12
12th Meeting of US-Japan Cooperation Medical Science Committee
1976
119/13
Meeting US-Japan
1971
119/14
Meeting US-Japan
1973
119/15
Meeting US-Japan
1972
120/1
Meeting 2nd Annual Conference Carcinogen Progress
1973
120/2
Micropart. Bed Chromo. Accel.d by Centrifuge
undated
120/3
Annual Meeting Infectious Disease Soc.
1970
120/4
Micropart. Gel Chromo. Accel. by Centrifuge
undated
120/5
Migrat. Inhibit., and Type II Interferon in Mycobact.
undated
120/6
Structure Req. of Microb. Agents as Immunization Potential for Tuberculosis,T
undated
120/7
Mss. Papers No Titles
undated
120/8
Miscellaneous
undated
120/9
Miscellaneous
undated
120/10
Miscellaneous on Endotoxins (ENT)
undated
120/11
Miscellaneous Notes, Fract. v. Hypothesis, Purpose
undated
120/12
Miscellaneous Notes
undated
120/13
Mod. of Host React. Prop of ENT by Sodium Deoxcholate
undated
120/14
Mod of Humoral/Cell Mediated Immunization Resp.by Nontox Lip.A
undated
120/15
Moieties of Mycobact. Mycolates to Induce Gran. React.
undated
120/16
Molecular concepts of Lipid "A"
undated
120/17
Monophos. Lipid"A" from Lipopolysacc. of S. Minne. R595
undated
120/18
Montreal Symposium
1976
120/19
Morph. of B. Tularense During Growth in Liquid byElectron Microscope
undated
120/20
Myco. Cellular Antigens Fract.
undated
120/21
Myco. CW Comp. in T Supr./Rgrss.
undated
120/22
Myco. Comp.s in Cancer Immunotherapy
undated
120/23
Myco. Comp.s Resp. for Gran. Inflammations
undated
120/24
Mycolic Acid of M.Rhodochrous, Nocardia Corallina
undated
120/25
NIH Lecture
1962
121/1
Nonclinical Study of Magreg Vaccine
undated
121/2
Nonspec.Immstim.for aero.Inf.Tuberculosis/Flu by Syn. MDP, TDP3
undated
121/3
N.Y. Academy of Science
1956
121/4
Occult ENT in Bacteria Protplasm
undated
121/5
ENT: Struct/Immunization of Host Resp.
undated
121/6
Others
undated
121/7
Others Cantrell Publications
undated
121/8
Others Cantrell Publications
undated
121/9
Others
undated
122/1
Others
undated
122/2
Others
undated
122/3
Others: The Piel Chromosomes Techniques
undated
122/4
Out line of Q-Fever Studies
undated
122/5
Orig/Prop of Naturally Occuring Hapten from E.Coli
undated
122/6
Overview of Membrane Filters
undated
122/7
Panel Discussions
1963
122/8
500 27 Paper II, Draft, Tables
undated
122/9
Part Purif. of Imm Material in Lipid Ext. of Mycobact.
undated
122/10
Parvum Paper
undated
122/11
Pas.Trans. of T by Spleen Cell from Cured Guinea Pig
undated
122/12
Peptide Req. Imm of Guinea Pig Line 10 T with ENT
undated
122/13
Phase I, II, Intra T Immunization by BCG Cell Wall Skeletons, P3
undated
122/14
Phase I, by Intra T, Intracavitary BCG Cell Wall Skeletons, P3
undated
122/15
Phase I, Intradermal Immunization by Oil-M. Smegatis Cell Wall Skeletons, TD
undated
122/16
Phys/Chem Changes in ENT Ass'd with Loss of Bio. Potent
undated
123/1
Physical/Chem Anal. of ENT from S. Enteritidis
undated
123/2
Physical of Reverse Inacttivation of ENT
undated
123/3
Phys ofAntigens Nat. Protopl. Polysacc. from E.Coli
undated
123/4
Physical Structure of Native Hapten
undated
123/5
Plasma-Depend Chemotaxis of Macrop.to BCG Cell Wall Skeletons, Mycobat GlyP3
undated
123/6
Preparation and Anti T Activity of Nontoxic Lipid "A"
undated
123/7
Prep/Host Reactive Propof ENT with Low N, and Lipid
undated
123/8
PreparationHostProp ofAl CitrateENT Complex of S. Enteri
undated
123/9
Preparation of CW/Protop. of Neisscria by Ribi Cell Fract.
undated
123/10
Prep of Microorg.s for Electron Microscope
undated
123/11
Prep of Adjuvant-Act Tuberculosisn Free Peptidogly. of Human Tuberculosis
undated
123/12
Prep, Prui. and Structure of ENT
undated
123/13
Preparationof 209: New Type "Bio. Resp. Modifier"
undated
123/14
Persentation in Berlin Germany
undated
123/15
Pres. Accel.Chromo by Micropart. Silica Columns
undated
123/16
Prevent of Pul. Gran. by AGN/Agents to Aero.Mycobat Tuberculosis
undated
123/17
Procedure for prep of Antigens by M. ParaTuberculosis
undated
123/18
Production Model Press for Progress Reportsep. of Bacteria Cell Walls
undated
123/19
Progress in the Search for a Tuberculosis Vaccine
undated
123/20
Prot. of Monkeys to AirborneTuberculosis by Aero Vacc of BCW's
undated
123/21
Prot. Effect of MDP with TDM to Aero Influ. Virus
undated
123/22
Purdue Lecture
1959
123/23
Purified THC, by Accel.d Micropart. Gel Chromo.
undated
124/1
Purification of THC, Tables and Graphs
undated
124/2
Nonliving Lipid Antigens from Lipposacc. of S.Typhimurium
undated
124/3
Puri. Synthetic THC Centri-Chromo in 8mm columns
undated
124/4
Purification of Q-Fever Rickettsiae by Density Gradient
undated
124/5
Reaction of ENT and Surfacants (I)
undated
124/6
(II) Immunization Props of ENT by Sodium Deoxycholate
undated
124/7
React. E. Coli ENT to Lithium Al Hydride
undated
124/8
React. of Papain Treated ENT
undated
124/9
Rgss. of Est. T's from ENT and Myco Fract.
undated
124/10
Rgss. of Line 10 Heptocel. Carc. by Micro Ext. Mycolates
124/11
Rgss. of T by ENT with Trehalose Myco. of Dif. Structure
undated
124/12
Rgss. of T by ENT and Myco Fract.
undated
124/13
Rgss. of T Induced Adju. Active Bacteria Comp.and Syn's
undated
124/14
Fine Lipid Antigens to Limulus Ameb. Lys.,Toxic, T Rgss. Activity
undated
124/15
Structure and Host React. Prop. of Microorganisms
undated
124/16
Chemical Comp to Biological Activity
undated
124/17
Physical Chem Change in ENT Lose of Potent by Acid Hydrol.
undated
124/18
Relat. Footpad to PPD Resistance Inf. Mycobat Tuberculosis in Mice Mycobat CW's
undated
124/19
Relate. Structure of Microorganisms to Host React. Props.
undated
124/20
Reprod of - ----, Antigens 352, S. Bedford B.H. CA 90212
undated
124/21
Resistance to Experiment Tuberculosis by Fract. Attn.d Tubercule Bacilli
undated
124/22
Resistance to Tuberculosis in Mice Immunizationd by BCG Disr.d in Oil
undated
125/1
Req. of Different Chemical Structure of ENT Gly. for T Rgss. Activity
undated
125/2
Immunization Chem Research Pub.s
undated
125/3
RIR-Mondino, ABS, 1981 CW-S S. Auveus
undated
125/4
Morph. Ele.s of Microorgs in Immunization/Phenomena
undated
125/5
Role of Mycobact. in Immunization of Cancer
undated
125/6
Rutger Symposium, Papers
1961
125/7
Rutger Symposium, Papers
1961
125/8
Rutger Symposium, Papers
1961
125/9
Rutger Symposium, Papers
1963
125/10
Science Writers Seminar (SElectron Microscope), Mar.
1964
125/11
Sci. Writers SElectron Microscope. 1986 Memo
undated
125/12
SElectron Microscope Fract. of B. Tularense Myco., Salmonella Spp., Histoplasm
undated
125/13
Sep./Chara. of Toxic/NonToxic Lipid A
undated
125/14
Sep./Imm Sign. of Antigens from Salmonella
undated
125/15
Sep. of ENT from Heptoseless Mutant of S.Typhimurium
undated
125/16
Sep. of Sugars by Centri-Chromo Micropart. Bed
undated
125/17
Sep. Trehalose 6,6 Dimycolates in Myco.Gly. Fract. P3
undated
125/18
Sep. Mycolic Acid Esters from Mycobact.
undated
125/19
Simple Preparation of Puri. Radioactive Polio Parts by Electron Microscope
undated
125/20
Site of Itracel. Antigens in 3 Non-Influ. myxovirus, Fluores.
undated
125/21
Skin React. by Typ/Nontyp. Myco. with Homo/Hetro Prot.
undated
125/22
Skin React. by CW and Proto. of Mycobat Tuberculosis, Mycobat Butricum
undated
125/23
Solub. of ENT, Stabil. of Biol. Activity in Organic Liq.
undated
125/24
Some Currents in Tuberculosis Research
undated
125/25
Phys/Chem/Biol of Antigens Liberated from S. Enter./S Typh.
undated
125/26
Spec/Nonspec. Stim. of Resist to Tuberculosis in Mice
undated
126/1
Spec/Nonspec. Stim of Resistance in Mice with Mycobat Tuberculosis H37RV
undated
126/2
Spec to Resistance Tuberculosis and Salmonellis by Oil-Treated CW's
undated
126/3
Stim. of Chemiluminescence by Nontox/Tox Lipid A
undated
126/4
Literature on CW's of Mycobact., Japan
undated
126/5
Delayed Reaction by Proto. of Acid-Fast Bacilli as AGN
undated
126/6
Proto of Acid-fast Bacilli Provoking Delay React in Guinea Pig
undated
126/7
Relate. Chemical Comp. and Biol. Prop. of ENT
undated
126/8
I) Biol.Prop. of Firm Bound Lipid v. Parent ENT
undated
126/9
II) Kinetic Study of Acid Hydolisis of ENT
undated
126/10
Study Prog. in Biophysical Sci., Boulder
1958
126/11
Strain, et al., Mss. Preps
undated
126/12
Structure/Biol Activity of ENT
undated
126/13
Structure/Biol Func. of Mycobact.
undated
126/14
Structure Req.s of Microbact. Agents, Montreal Symposium, Ms
undated
126/15
Structure Req.s Microb. Agents for Immthpy. of Guinea Pig Line 10 T
undated
126/16
Structure/Biological Function of Mycobacteria
undated
126/17
Structure/Biological Function of Mycobacteria, Annual New York Academy of Science
undated
127/1
Struct/Func of Bacteria Adjuvants
undated
127/2
Struct/Func Relate. of Myco. Comp/Detox.d Ext.Re Mutant
undated
127/4
Struct/Func Relate. of LipidAntigens to Enhance Anti T Activity
undated
127/5
Structured Ele. of Hist. Caps., Role in Immunization to Experiment Dis.
undated
127/6
Struct Moieties of MycoLipid for Prod.of Gran. React.
undated
127/7
Struct Req. of ENT Gly.for anti T/Toxic Activity
undated
127/8
Struct Req. for Microb. Agents in Imm of Line 10 in Guinea Pig
undated
127/9
Submicro. Structure of Fibres, Formation
undated
127/10
Summ of Prog. on Centri-Chromo of Lipids
undated
127/11
Summ Rpt. on ChemicalComp./Biol.Prop.of ENT of S.Enterit.
undated
127/12
Sup. of Intravein. BCG/BCG-CW in R.Monkey to Airborn Tuberculosis
undated
127/13
Sprss/Rgss Line 10 T Guinea Pig Hept.by MAAF and P3
undated
127/14
Sprss T Growth/Rgrss of Est.T byOil Att.dMyco Fract.
undated
127/15
Symposium, Annual Meeting: Amer. Chemical Soc., Kansas
1982
127/16
Symposium, ASM Meeting, Cleveland
1963
127/17
Symposium, Host Reactive Prop. of CW from Mycobact.
1963
128/1
Symposium, Bactoremic Shock, Manu.,Prep,Puri.Struct
1964
128/2
Symposium, on Bacteria ENT,I) Chemical Comp to Biol Activity
undated
128/3
Symposium, on Biotech. Devel. in Bacteria Vaccine Prod.
undated
128/4
Symposium, on ENT
undated
128/5
Symposium, on ENT Relate. Chemical Comp.to Biol Activity
1963
128/6
Symposium, Struct/Biol Prop. of Surface Antigens of Gm-Neg Bact
undated
128/7
Symposium, on ENT of Comp/Struct Relate to Biol. Activity
undated
128/8
Symposium, of Immunization of Cancer, Japan 9 18-20
1985
128/9
Symposium, Relate Structure of Microorg. to Immunization Props, Hosts
undated
128/10
III) Struct/Biol Prop of Surface Antigens of Gm-Neg Bact
undated
128/11
Symposium, Papers, Presented Stockholm, Paris, Ottawa
1971
128/12
Symposium, Shock Tour
undated
128/13
Syner.Activity of Mycoand Mutant Sal.in Rgss in Line 10 Guinea Pig
undated
128/14
Syner Rgss after Line 10 Cars.by Deprot. BCG-CW, S.Typ
undated
128/15
Syn. and Nat. Trehalose Fatty Acid Esters in T Rgss
undated
128/16
Taxo.Class of Myco through Collaborations Micropart. Gel C
undated
128/17
Thesis
undated
128/18
TLC, Literature Notes, Chloreserol Esters
undated
128/19
Mod. App. of Ribi Products with CY's and BRM's
undated
128/20
Tox. and Antigens Prop of Fract. of Q-Fever Rickettsiae
undated
128/21
Tox/Pyro/Mitogenic Prop of Fract of a RExperiment Mutant ENT
undated
128/22
Treat Melanoma by Low CY Autologus Mel.Detox ENT, BCG
undated
128/23
TDM of Myco.spp, Dif. AntiInf. Activity with MDP
undated
128/24
Trehalose Palmitates in T Rgss, Planned Pub.s
undated
128/25
Tuberculosis
undated
129/1
Tuberculosis Shortened Syn. of Adjuvant MDP
undated
129/2
Tuberculosis Meeting Hamilton MT
1965
129/3
T Rgss with MAAF and P3
undated
129/4
T Rgss Caused by ENT with TDM
undated
129/5
T Rgss Caused by ENT with Myco. TDM
undated
129/6
T Rgss Caused by ENT with Myco. Fract.
undated
129/7
T Rgss by Oil/Water Emulsion Mediated to Oil
undated
129/8
T Rgss Mediated by Bacteria Glycolipids
undated
129/9
T Rgss Mediated by Comp.s of Myco.
undated
129/10
T Rgss by Nontoxic Microbial Comp.s
undated
129/11
T Rgss of Q-Fever Rickettsiae and Myco. Glycolipid
undated
129/12
T Spss by Cw of M. Bovis on Oil Droplets
undated
129/13
Uber den Feinbau der Viscosseide
undated
129/14
Uber den Feinbau der Cellulose
undated
129/15
Uber Hydroxyuerbindungen des Mangans
undated
129/16
Ultrastruct. of Exosporium enveloping spores Bac.Cereus
undated
129/17
ENT in Cancer Imm and Chara. of Nontox. Lipid Comps
undated
129/18
Use of Pres. Cell to Preparation CW from Myco.
undated
129/19
9th Joint Tuberculosis Conference Kyoto, Japan
undated
129/20
10th US-Japan Tuberculosis Res. Conference, Big Sky, Montana
1975
129/21
US-Japan 5 year Report
1970-1975
129/22
US-Japan Coop. Medical Science Program
undated
129/23
US-Japan Coop. Medical Science Program
1977
129/24
US Tuberculosis Panel
undated
129/25
US-Japan Tuberculosis Conference San Fransico, CA
1971
129/26
X-Ray Anal. of Swelling Woodpulp by Sodium Hydroixde
undated
129/27
Zur Derzeitigen Exp und Klinischen Unspec. Imm Krebses
undated
129/28
Zur Electron Microscope Preparation von Kolloiden
undated

Series V:  Ribi ImmunoChem, 1981-1986Return to Top

4.0 linear feet

The materials in this series document the efforts of Edgar Ribi and his associates to organize, incorporate, secure investors, and manage Ribi ImmunoChem, a private company focused on developing anti-cancer agents, anti-infectious agents, and super vaccines. Company records include Board of Directors records and correspondence, internal memos, legal documents (particularly patent and liability declarations), publicity materials, product development documentation, Ribi's personal notes, and financial records.

Container(s) Description Dates
Subseries 1: Company
3.0 linear feet
1981-1986
Box/Folder
130/1
Board of Directors, General
1984-1986
130/2
Board of Directors Meeting
April 1985
130/3
Board of Directors Meeting
June 1985
130/4
Board of Directors Meeting
September 1985
130/5
Board of Directors Meeting
December 1985
130/6
Board of Directors Meeting
April 1986
130/7
Board of Directors Meeting
June 1986
130/8
Intracompany Memos
1985
131/1
Intracompany Memos
1985
131/2
Intracompany Memos
1985
131/3
Intracompany Memos
1985
131/4
Intracompany Memos
1986
131/5
Intracompany Memos
1986
131/6
Legal Document, Employment Agreement
1985
131/7
Legal Document, Bond Issue
1981
131/8
Publicity and Clippings
1982-1986
132/1
Product Development, General Correspondence and Notes
1982-1984
132/2
Product Development, General Correspondence and Notes
1983-1984
132/3
Product Development, Presentation, March
1984
132/4
Product Development, Presentation to Johnson and Johnson
June 1984
132/5
Product Development, Animal Vaccine Adjuvant/Human Vaccine Adjuvant and RibiGen
1985
132/6
Product Development, Brucella Vaccine and RibiGen Adjuvant Scale-Up
1985
133/1
Product Development, Detox, Ovamid and Polymerized Liposomal Adjuvants
1985
133/2
Product Development, Paratuberculosis and Bovine Brucellosis Diagnostics
1985-1986
133/3
Product Development, Ovamid, Detox, RibiGen Adjuvant Scale-Up and Adjuvant Research
1985-1986
133/4
Product Development, Bovine Brucellosis Diagnostic and Brucella Vaccine
1986
133/5
Product Development, Triple Mixture, Animal Vaccine Adjuvant, Human Cancer Preclinical, Human Vaccine Adjuvant, NSR/Endotoxemia/Immuno-deficiency
1986
134/1
General Notes and Articles
1984-1986
134/2
General Notes
1984
134/3
General Notes
1985
134/4
General Notes
1985-1986
Subseries 2: Financial
1.0 linear feet
1981-1984
Box/Folder
135/1
Statements
1984
135/2
Statements
1984
135/3
Statements
1984
135/4
Statements
1984
135/5
Statements
1983
135/6
Statements
1983
130/7
Statements
1983
135/8
Statements
1982
135/9
Statements
1981
136/1
Product Outlets/Shipments Blackbook
undated
136/2
Prospectus
undated
136/3
S.B.A. Inventory Res. Proposal
1985
136/4
Production Schedule
1981
136/5
BCG CW Distribution Record
undated
136/6
Shares, References
undated
136/7
RibiGen, Regression
undated
136/8
Good Management Practices, Code of Federal Regulations, Food and Drug Administration
undated
136/9
Expanded Business Plan
1985
136/10
Microfluids
undated
136/11
Memos on Invention
undated
136/12
Patents, Legal Challenge
undated
136/13
Public Relations, RibiGen Cell Wall Skeletons-TDM
undated
136/14
Public Relations RibiGen Cell Wall Skeletons-TDM
undated
136/15
Product Capacity, Cost Analysis, P3 and MPL
undated

Series VI:  Electron Micrographs, undatedReturn to Top

5.5 linear feet

This series consists of 4653 electron micrographs, photographs of specimens taken through an electron microscope. These images were likely created during Ribi's research for the National Institute of Allergy and Infectious Diseases Laboratory in Hamilton, Montana.

Container(s) Description Dates
Box
137
Reference list to electron micrographs and electron microscope operator's manual
undated
138
Electron micrographs, #4969-5473
139
Electron micrographs, #5474-6239
140
Electron micrographs, #6240-6966
141
Electron micrographs, #6993-7591
142
Electron micrographs, #A1-A100
Electron micrographs, #B1-B100
Electron micrographs, #C1-C100
Electron micrographs, #D1-D100
Box
143
Electron micrographs, #E18-E100
Electron micrographs, #F1-F100
Electron micrographs, #G3-G18
Electron micrographs, #G72-G94
Electron micrographs, #H19-H100
Electron micrographs, #I1-#100
Electron micrographs, #J1-J100
Electron micrographs, #K1-K100
Electron micrographs, #L1-L12
Box
144
Electron micrographs, #L13-L100
Electron micrographs, #M1-M100
Electron micrographs, #N1-N100
Electron micrographs, #O1-O100
Electron micrographs, #P1-P12
Box
145
Electron micrographs, #P13-P100
Electron micrographs, #Q1-Q100
Electron micrographs, #R1-R95
Electron micrographs, #S7-S100
Box
146
Electron micrographs, #T1-T100
Electron micrographs, #U1-U100
Electron micrographs, #V1-V57

Series VII:  Chromatographs, undatedReturn to Top

0.5 linear feet

This series consists of 470 chromatographs, a technique of separating and analyzing the components of a mixture of liquids or gases by selective adsorption and depicted as a column or strip of material ranges. These chromatographs were likely created during Ribi's research for the National Institute of Allergy and Infectious Diseases Laboratory in Hamilton, Montana.

Container(s) Description Dates
Box
147
Chromatographs, #S1-S343
147
Chromatographs, #SV1-SV127

Series VIII:  Photographs, 1928-1975Return to Top

9 images

This series contains 9 photographs of Edgar Ribi and the Rocky Mountain Laboratory facilities in Hamilton, Montana. Included are two images of early facilities and one from 1963 that also captures the western portion of the Bitterroot Valley in 1963.

Container(s) Description Dates
Box/Folder photo_number
137/1 197(VIII):1
Edgar Ribi, Lecturing
circa 1975
137/1 197(VIII):2
Edgar Ribi with a group of men, Big Sky, Montana
1975
137/1 197(VIII):3
Doctors Edgar Ribi and Carl L. Larson examining fractions of M. tuberculaturn through an electron microscope
circa 1965
137/1 197(VIII):4
Doctor Ribi, at blackboard, his professional staff, and foreign researchrs during an informal seminar
1965
137/1 197(VIII):5
Technical services at Rocky Mountian Lab, a few stacks in the medical library
1964
137/1 197(VIII):6
Technical services at Rocky Mountian Lab, animal research areas
circa 1964
137/1 197(VIII):7
U.S. Public Health Service Laboratory building, Hamilton, Montana
circa 1920s-1930s
137/1 197(VIII):8
Montana State Board of Entomology building, housed the U.S. Public Health Service Spotted Fever Laboratory, Hamilton, Montana
1928
137/1 197(VIII):9
Rocky Mountain Laboratory complex and west neighborhoods of Hamilton, Montana
1963

Names and SubjectsReturn to Top

Subject Terms

  • Biochemistry--Research -- Montana--Hamilton
  • Communicable diseases -- Research--Montana--Hamilton
  • Immunology--R esearch -- Montana--Hamilton
  • Oncology--Research -- Montana--Hamilton
  • Swiss Americans -- Montana

Corporate Names

  • National Institute of Allergy and Infectious Diseases (U.S.)
  • National Institutes of Health (U.S.)
  • National Institutes of Health (U.S.). Rocky Mountain Laboratory

Occupations

  • Biophysicists--Montana --Hamilton
  • Businessmen--Montana --Hamilton

Other Creators

  • Corporate Names
    • Ribi ImmunoChem Research, Inc.